Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Aarti Drugs Limited ( (IN:AARTIDRUGS) ) has issued an update.
Aarti Drugs Limited has released its Business Responsibility and Sustainability Report for the financial year 2024-25. This report, which aligns with SEBI’s listing regulations, highlights the company’s commitment to sustainable business practices and is available on their website. The report underscores Aarti Drugs’ dedication to responsible business operations, which could enhance its market positioning and stakeholder relations.
More about Aarti Drugs Limited
Aarti Drugs Limited is a company operating in the pharmaceuticals industry, primarily engaged in the manufacturing and marketing of pharmaceuticals and chemical products. The company’s main products include Active Pharmaceutical Ingredients (APIs), specialty chemicals, and intermediates, contributing significantly to its turnover.
Average Trading Volume: 33,129
Technical Sentiment Signal: Buy
Current Market Cap: 42.85B INR
For a thorough assessment of AARTIDRUGS stock, go to TipRanks’ Stock Analysis page.